ExPLoRNA Therapeutics

ExPLoRNA Therapeutics is a biotechnology company in Poland that develops groundbreaking innovations in mRNA as a therapeutic platform, applying these solutions to unique therapeutic projects and providing technology, therapeutic platforms, and therapies to pharmaceutical partners. ExPLoRNA Therapeutics is developing its unique mRNA technology, which is set to revolutionize mRNA vaccines and treatments. This technology aims to better understand the benefits of ExPLoRNA's cap analogs, particularly in reducing the mRNA dosage required for therapeutic effects in vaccination and monoclonal antibody production settings.